Advertisement


Kelly K. Hunt, MD, on Breast Cancer and Neoadjuvant Therapy: Expert Commentary

AACR Annual Meeting 2024

Advertisement

Kelly K. Hunt, MD, of The University of Texas MD Anderson Cancer Center, discusses the benefits to patients with neoadjuvant therapy in advanced, inoperable breast cancer, for whom this treatment works best, and novel approaches currently under investigation.



Related Videos

Lung Cancer

Pasi A. Jänne, MD, PhD, on NSCLC, Osimertinib, Chemotherapy: Update From FLAURA2

Pasi A. Jänne, MD, PhD, of Dana-Farber Cancer Institute, discusses an exploratory analysis from the FLAURA2 study, which indicates that baseline levels of plasma EGFR mutation may be prognostic and predictive of clinical benefit with osimertinib plus chemotherapy vs osimertinib alone for patients with non–small cell lung cancer (NSCLC).

Advertisement

Advertisement




Advertisement